Financial Snapshot

Revenue
$1.368M
TTM
Gross Margin
-44.99%
TTM
Net Earnings
-$331.5M
TTM
Current Assets
$166.3M
Q4 2023
Current Liabilities
$32.59M
Q4 2023
Current Ratio
510.39%
Q4 2023
Total Assets
$166.5M
Q4 2023
Total Liabilities
$213.4M
Q4 2023
Book Value
-$46.91M
Q4 2023
Cash
$66.64M
Q4 2023
P/E
-1.987
Sep 18, 2024 EST
Free Cash Flow
-$232.6M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $108.4K $90.68K $68.61K $59.06K $110.2K $792.2K $397.2K $530.0K $939.0K $880.0K $1.150M $1.490M $1.830M $2.270M $3.090M $8.150M $29.89M $1.170M $47.40M $7.270M $860.0K $1.870M $1.650M $3.220M $4.400M $310.0K
YoY Change 19.55% 32.17% 16.17% -46.39% -86.09% 99.47% -25.07% -43.55% 6.71% -23.48% -22.82% -18.58% -19.38% -26.54% -62.09% -72.73% 2454.7% -97.53% 551.99% 745.35% -54.01% 13.33% -48.76% -26.82% 1319.35%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $108.4K $90.68K $68.61K $59.06K $110.2K $792.2K $397.2K $530.0K $939.0K $880.0K $1.150M $1.490M $1.830M $2.270M $3.090M $8.150M $29.89M $1.170M $47.40M $7.270M $860.0K $1.870M $1.650M $3.220M $4.400M $310.0K
Cost Of Revenue $166.8K $160.5K $428.9K $357.0K $189.7K $178.9K $178.3K $241.3K $344.7K $570.0K $620.0K $1.540M $710.0K $1.160M $2.030M $1.950M $9.910M $410.0K $150.0K $150.0K $180.0K $80.00K $80.00K $80.00K
Gross Profit -$58.42K -$69.82K -$360.3K -$297.9K -$79.57K $613.3K $218.8K $288.7K $594.3K $310.0K $540.0K -$50.00K $1.120M $1.110M $1.060M $6.200M $19.97M $760.0K $47.25M $7.120M $680.0K $1.790M $1.570M $3.140M
Gross Profit Margin -53.89% -77.0% -525.13% -504.44% -72.22% 77.42% 55.1% 54.47% 63.29% 35.23% 46.96% -3.36% 61.2% 48.9% 34.3% 76.07% 66.81% 64.96% 99.68% 97.94% 79.07% 95.72% 95.15% 97.52%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Selling, General & Admin $26.73M $17.00M $13.31M $4.628M $3.637M $3.276M $3.309M $2.857M $3.416M $3.390M $3.620M $3.720M $4.330M $5.370M $4.670M $3.630M $3.990M $2.750M $2.160M $1.920M $1.960M $2.020M $1.880M $1.390M $40.00K $80.00K
YoY Change 57.24% 27.71% 187.58% 27.27% 10.99% -0.98% 15.83% -16.36% 0.75% -6.35% -2.69% -14.09% -19.37% 14.99% 28.65% -9.02% 45.09% 27.31% 12.5% -2.04% -2.97% 7.45% 35.25% 3375.0% -50.0%
% of Gross Profit 534.22% 1511.98% 989.41% 574.74% 1093.55% 670.37% 386.61% 483.78% 440.57% 58.55% 19.98% 361.84% 4.57% 26.97% 288.24% 112.85% 119.75% 44.27%
Research & Development $122.1M $78.65M $25.89M $12.06M $21.71M $17.24M $3.351M $2.480M $5.586M $3.610M $3.440M $3.600M $6.570M $4.300M $4.480M $3.420M $3.160M $1.080M $700.0K $500.0K $160.0K $260.0K $690.0K $310.0K $540.0K $970.0K
YoY Change 55.27% 203.78% 114.62% -44.44% 25.94% 414.47% 35.1% -55.59% 54.73% 4.94% -4.44% -45.21% 52.79% -4.02% 30.99% 8.23% 192.59% 54.29% 40.0% 212.5% -38.46% -62.32% 122.58% -42.59% -44.33%
% of Gross Profit 2810.95% 1531.3% 859.11% 939.92% 1164.52% 637.04% 586.61% 387.39% 422.64% 55.16% 15.82% 142.11% 1.48% 7.02% 23.53% 14.53% 43.95% 9.87%
Depreciation & Amortization $101.2K $78.38K $106.7K $96.54K $22.92K $19.85K $18.43K $21.33K $38.56K $40.00K $30.00K $30.00K $30.00K $20.00K $20.00K
YoY Change 29.15% -26.52% 10.49% 321.24% 15.46% 7.7% -13.58% -44.7% -3.6% 33.33% 0.0% 0.0% 0.0%
% of Gross Profit 3.24% 8.42% 7.39% 6.49% 12.9% 5.56% 2.68%
Operating Expenses $150.2M $96.58M $39.31M $16.79M $25.37M $20.54M $6.678M $5.358M $9.040M $7.030M $7.530M $7.660M $11.21M $9.680M $9.180M $7.050M $7.180M $4.370M $2.860M $2.420M $2.150M $2.940M $3.160M $1.810M $5.940M $2.280M
YoY Change 55.57% 145.69% 134.13% -33.83% 23.54% 207.51% 24.63% -40.72% 28.59% -6.64% -1.7% -31.67% 15.81% 5.45% 30.21% -1.81% 64.3% 52.8% 18.18% 12.56% -26.87% -6.96% 74.59% -69.53% 160.53%
Operating Profit -$150.3M -$96.65M -$39.67M -$17.09M -$25.45M -$19.92M -$6.459M -$5.070M -$8.445M -$6.720M -$6.990M -$7.710M -$10.09M -$8.570M -$8.120M -$850.0K $12.79M -$3.610M $44.39M $4.700M -$1.470M -$1.150M -$1.590M $1.330M
YoY Change 55.52% 143.63% 132.16% -32.86% 27.75% 208.43% 27.41% -39.97% 25.68% -3.86% -9.34% -23.59% 17.74% 5.54% 855.29% -106.65% -454.29% -108.13% 844.47% -419.73% 27.83% -27.67% -219.55%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Interest Expense $1.578M -$2.579M -$10.64M $214.5K $774.6K -$108.3K -$26.80K -$42.88K $261.7K $200.0K $430.0K $220.0K -$330.0K $2.890M -$1.280M -$220.0K -$740.0K -$1.760M -$17.10M -$130.0K -$30.00K -$430.0K -$40.00K -$100.0K
YoY Change -161.21% -75.77% -5061.28% -72.31% -814.92% 304.21% -37.49% -116.39% 30.83% -53.49% 95.45% -166.67% -111.42% -325.78% 481.82% -70.27% -57.95% -89.71% 13053.85% 333.33% -93.02% 975.0% -60.0%
% of Operating Profit -5.79% -38.52% -2.77% -7.52%
Other Income/Expense, Net $276.9K $108.3K $26.95K $41.63K $56.14K $1.919K $1.108K $5.776K $62.58K $190.0K $30.00K $180.0K $0.00 $0.00 $0.00 $10.00K $150.0K $0.00 $0.00
YoY Change 155.6% 301.93% -35.26% -25.84% 2825.22% 73.19% -80.82% -90.77% -67.06% 533.33% -83.33% -100.0% -93.33%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Pretax Income -$148.4M -$99.12M -$50.28M -$16.83M -$24.62M -$20.03M -$6.483M -$5.611M -$8.121M -$6.850M -$6.560M -$7.310M -$11.04M -$6.840M -$9.880M -$1.120M $12.02M -$6.180M $21.77M $5.800M -$3.630M -$5.740M -$1.620M $1.220M $2.370M -$1.980M
YoY Change 49.77% 97.12% 198.74% -31.63% 22.92% 208.94% 15.55% -30.91% 18.56% 4.42% -10.26% -33.79% 61.4% -30.77% 782.14% -109.32% -294.5% -128.39% 275.34% -259.78% -36.76% 254.32% -232.79% -48.52% -219.7%
Income Tax -$5.926M -$6.299M -$4.939M -$5.709M -$10.14M -$8.323M -$2.194M -$1.087M -$2.720M -$2.860M -$1.560M -$2.400M -$780.0K $110.0K $50.00K $1.170M $5.720M $340.0K $0.00 $0.00 -$120.0K $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 47.59% 0.0% 0.0% 0.0% 0.0%
Net Earnings -$142.5M -$92.82M -$45.34M -$11.12M -$14.48M -$11.71M -$4.289M -$4.507M -$5.312M -$4.000M -$4.750M -$4.840M -$10.27M -$6.950M -$9.920M -$1.150M $11.20M -$6.470M $21.77M $5.800M -$3.510M -$5.740M -$1.620M $1.220M $2.370M -$1.980M
YoY Change 53.55% 104.69% 307.66% -23.19% 23.71% 172.93% -4.83% -15.15% 32.8% -15.79% -1.86% -52.87% 47.77% -29.94% 762.61% -110.27% -273.11% -129.72% 275.34% -265.24% -38.85% 254.32% -232.79% -48.52% -219.7%
Net Earnings / Revenue -131464.89% -102357.05% -66090.22% -18833.73% -13146.06% -1477.7% -1079.99% -850.34% -565.71% -454.55% -413.04% -324.83% -561.2% -306.17% -321.04% -14.11% 37.47% -552.99% 45.93% 79.78% -408.14% -306.95% -98.18% 37.89% 53.86% -638.71%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.30 -$264.0K -$141.5K -$42.65K -$62.21K -$58.07K -$26.60K -$30.01K -$48.69K -$80.39K -$95.55K -$101.6K -$217.0K -$150.1K -$217.3K -$28.01K $271.1K -$157.6K $530.3K $141.1K -$83.08K -$136.0K -$38.72K $36.29K $73.10K -$65.05K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Cash & Short-Term Investments $89.19M $44.63M $118.2M $42.65M $14.92M $22.52M $35.99M $10.15M $11.00M $16.44M $22.10M $31.86M $38.84M $46.22M $48.19M $14.61M $24.83M $17.50M $14.70M $20.06M $25.63M $14.26M $5.030M $1.990M
YoY Change 99.83% -62.24% 177.12% 185.96% -33.76% -37.43% 254.54% -33.09% -25.61% -30.63% -17.97% -15.97% -4.09% 229.84% -41.16% 41.89% 19.05% -26.72% -21.73% 79.73% 183.5% 152.76%
Cash & Equivalents $77.12M $32.78M $102.7M $40.57M $14.20M $20.43M $35.99M $10.03M $8.500M $12.55M $20.00M $27.00M $37.01M $45.21M $45.95M $9.680M $150.0K $70.00K $20.00K $50.00K $220.0K $13.80M $4.920M $1.900M
Short-Term Investments $0.00 $117.1K
Other Short-Term Assets $2.635M $8.720M $14.39M $329.2K $294.1K $202.4K $106.6K $126.1K $140.0K $70.00K $80.00K $70.00K $110.0K $320.0K $200.0K $13.74M $260.0K $300.0K $200.0K $160.0K $220.0K $30.00K $20.00K $190.0K
YoY Change -69.79% -39.38% 4270.7% 11.93% 45.28% 89.83% -15.43% 100.0% -12.5% 14.29% -36.36% -65.63% 60.0% -98.54% 5184.62% -13.33% 50.0% 25.0% -27.27% 633.33% 50.0% -89.47%
Inventory
Prepaid Expenses
Receivables $352.5K $153.1K $210.0K $360.0K $470.0K $450.0K $280.0K $110.0K $40.00K $20.00K $20.00K $10.00K $30.00K $110.0K $20.00K $20.00K
Other Receivables $1.877M $1.099M $0.00 $0.00 $0.00 $90.00K $30.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $98.39M $59.91M $138.1M $49.04M $25.55M $31.31M $38.32M $11.53M $13.47M $18.17M $22.39M $32.28M $39.42M $47.08M $48.71M $28.46M $25.13M $17.82M $14.92M $20.22M $25.89M $14.40M $5.060M $2.200M
YoY Change 64.23% -56.63% 181.62% 91.94% -18.4% -18.29% 232.42% -25.87% -18.85% -30.64% -18.11% -16.27% -3.35% 71.15% 13.25% 41.02% 19.44% -26.21% -21.9% 79.79% 184.58% 130.0%
Property, Plant & Equipment $201.5K $28.08K $117.1K $193.0K $37.44K $47.85K $44.22K $63.13K $80.00K $110.0K $100.0K $50.00K $70.00K $80.00K $80.00K $50.00K $40.00K $50.00K $70.00K $80.00K $100.0K $90.00K $80.00K $90.00K
YoY Change 617.56% -76.02% -39.33% 415.54% -21.75% 8.22% -29.96% -27.27% 10.0% 100.0% -28.57% -12.5% 0.0% 60.0% 25.0% -20.0% -28.57% -12.5% -20.0% 11.11% 12.5% -11.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $199.4K $494.6K $549.4K $795.3K $218.8K $2.280M $3.650M $1.820M $2.280M $1.640M $6.280M $17.88M $29.12M $17.26M $23.73M $21.32M $20.87M $21.21M $10.38M $2.030M $2.050M
YoY Change -100.0% -59.68% -9.98% -30.91% 263.47% -37.53% 100.55% -20.18% 39.02% -73.89% -64.88% -38.6% 68.71% -27.27% 11.3% 2.16% -1.6% 104.34% 411.33% -0.98%
Other Assets $53.54K $110.3K $174.5K $0.00 $80.00K $180.0K $190.0K $50.00K $150.0K $420.0K $190.0K $1.230M
YoY Change -51.46% -36.81% -55.56% -5.26% 280.0% -66.67% -64.29% 121.05% -84.55%
Total Long-Term Assets $255.0K $138.4K $291.7K $392.5K $532.0K $597.3K $839.5K $281.9K $2.940M $4.430M $2.110M $2.390M $1.860M $6.770M $18.15M $30.55M $18.04M $24.32M $21.94M $21.50M $21.86M $11.09M $2.240M $2.290M
YoY Change 84.29% -52.55% -25.68% -26.24% -10.92% -28.85% 197.77% -33.63% 109.95% -11.72% 28.49% -72.53% -62.7% -40.59% 69.35% -25.82% 10.85% 2.05% -1.65% 97.11% 395.09% -2.18%
Total Assets $98.64M $60.05M $138.4M $49.44M $26.08M $31.91M $39.16M $11.81M $16.41M $22.60M $24.50M $34.67M $41.28M $53.85M $66.86M $59.01M $43.17M $42.14M $36.86M $41.72M $47.75M $25.49M $7.300M $4.490M
YoY Change
Accounts Payable $17.84M $11.40M $2.418M $4.178M $4.101M $5.003M $1.110M $1.129M $1.340M $1.680M $2.000M $2.120M $1.740M $1.370M $2.240M $0.00 $40.00K
YoY Change 56.49% 371.61% -42.14% 1.88% -18.02% 350.57% -1.65% -20.24% -16.0% -5.66% 21.84% 27.01% -38.84% -100.0%
Accrued Expenses $802.2K $639.5K $492.0K $440.8K $373.0K $318.2K $277.4K $162.8K $0.00 $0.00 $10.00K $110.0K $70.00K $0.00 $950.0K $280.0K $130.0K $150.0K $80.00K $60.00K $240.0K $60.00K $90.00K
YoY Change 25.43% 29.99% 11.62% 18.17% 17.22% 70.34% -100.0% -90.91% 57.14% 239.29% 115.38% -13.33% 87.5% 33.33% -75.0% 300.0% -33.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $97.49K $0.00 $113.0K $99.75K $89.39K $0.00 $14.55K $0.00 $5.000M
YoY Change -100.0% 13.25% -100.0% -100.0%
Total Short-Term Liabilities $18.74M $12.04M $3.106M $4.758M $4.513M $5.447M $1.387M $1.394M $277.4K $162.8K $1.910M $2.130M $2.440M $2.660M $2.330M $1.790M $3.100M $1.310M $5.600M $430.0K $460.0K $190.0K $190.0K $290.0K $90.00K $120.0K
YoY Change 55.65% 287.63% -34.71% 5.43% -17.14% 292.66% -0.47% 402.47% 70.34% -91.47% -10.33% -12.7% -8.27% 14.16% 30.17% -42.26% 136.64% -76.61% 1202.33% -6.52% 142.11% 0.0% -34.48% 222.22% -25.0%
Long-Term Debt $85.74M $0.00 $0.00 $82.55K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $7.630K $27.97K $16.92K $27.64K $17.20K $27.29K $34.60K $43.12K $70.00K $110.0K $50.00K $30.00K $20.00K $10.00K $30.00K $40.00K $30.00K $20.00K $20.00K $180.0K $130.0K $70.00K $50.00K $40.00K
YoY Change -72.72% 65.31% -38.78% 60.66% -36.96% -21.13% -19.76% -36.36% 120.0% 66.67% 50.0% 100.0% -66.67% -25.0% 33.33% 50.0% 0.0% -88.89% 38.46% 85.71% 40.0% 25.0%
Total Long-Term Liabilities $85.75M $27.97K $16.92K $110.2K $17.20K $27.29K $34.60K $43.12K $70.00K $110.0K $50.00K $30.00K $20.00K $10.00K $30.00K $40.00K $30.00K $20.00K $20.00K $180.0K $130.0K $70.00K $50.00K $40.00K
YoY Change 306485.13% 65.31% -84.64% 540.49% -36.96% -21.13% -19.76% -36.36% 120.0% 66.67% 50.0% 100.0% -66.67% -25.0% 33.33% 50.0% 0.0% -88.89% 38.46% 85.71% 40.0% 25.0%
Total Liabilities $104.5M $12.07M $3.123M $4.868M $4.530M $5.474M $1.422M $1.437M $2.960M $3.690M $2.680M $2.850M $2.530M $6.430M $11.01M $2.420M $5.770M $450.0K $470.0K $370.0K $770.0K $370.0K $140.0K $160.0K
YoY Change 765.76% 286.43% -35.84% 7.46% -17.24% 285.03% -1.05% -19.78% 37.69% -5.96% 12.65% -60.65% -41.6% 354.96% -58.06% 1182.22% -4.26% 27.03% -51.95% 108.11% 164.29% -12.5%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $658.64 Million

About

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. The company is headquartered in Melbourne, Victoria. The firm is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The firm has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).

Industry: Biological Products, (No Diagnostic Substances) Peers: